Journal of Evidence-Based Integrative Medicine

SJR Rank #9,577H-index: 63SJR: 0.614Best quartile: Q1Open AccessAPC: US$2,000Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Complementary and Alternative MedicineQ1

Areas: Medicine

Most published research topics

Complementary and Alternative Medicine StudiesEthnobotanical and Medicinal Plants StudiesNatural Antidiabetic Agents StudiesEssential Oils and Antimicrobial ActivityMindfulness and Compassion InterventionsAcupuncture Treatment Research StudiesPharmacological Effects of Natural CompoundsPhytochemicals and Antioxidant ActivitiesPain Management and Placebo EffectMusculoskeletal pain and rehabilitation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs015304560

Documents per Year

2022202506121824

Detailed Information

ISSN

2515-690X

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.71

References per Document

42.52

Coverage

2018-2026

Scope

The Journal of Evidence-Based Integrative Medicine (JEBIM) is an interdisciplinary, peer-reviewed, open access, biomedical journal whose aim is to create a global platform for hypothesis-driven and evidence-based research in all fields of integrative medicine. The journal’s objective is to publish papers which impart scientific validity to Integrative Medicine methods that are indispensable and inevitable in today’s world. All papers will be peer reviewed by experts in their respective fields, and papers will be accepted based on their scientific merit. It is the goal of the Journal to help remove the “myth” and provide scientific rationale for the various methodologies and theories of Integrative Medicine. All submissions will be reviewed based on their scientific merit and only papers with sound study design, valid statistical analyses and logical conclusions will be accepted.

Metrics from SCImago Journal Rank 2025. View on SCImago